Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
FDA Warns Against Use of Compounded Versions of Ozempic, WegovySome compounded versions of Ozempic and Wegovy use salt forms of the active ingredient which have not been tested or approved by the agency. June 1, 2023 Irvin Jackson Add Your CommentsConsumers should be careful about the use of compounded versions of the diabetes drugs Ozempic and Wegovy, because they may be made with unauthorized and untested, ingredients, according to a new warning from federal drug regulators.The U.S. Food and Drug Administration (FDA) issued a drug statement communication on May 31, warning about risks that may result from the increasing use of Ozempic and Wegovy for weight loss, which are often made by compounding pharmacies. However, the agency indicates that some compounding pharmacies are using unapproved versions of the active ingredient, semaglutide, which may put users at risk and which has been linked to adverse event reports from patients.Ozempic (semaglutide) was originally approved for the treatment of people with Type 2 diabetes. However, in recent monthsย Ozempic has been widely prescribed for weight loss. Although the diabetes drug Wegovy is approved for weight loss use, Ozempic is not and it is increasingly prescribed โoff-labelโ as a diet medication.Compounded Ozempic and Wegovy May Use Unsafe IngredientsThe move toward using the two drugs as weight loss treatments, as well as other supply chain factors, have resulted in a shortage of the two medications. During such shortages, compounding pharmacies may be allowed to make in-house versions of the drugs for customers, but they must meet FDA standards and use approved ingredients.Both Ozempic and Wegovy are currently listed on the FDAโs drug shortage list, which makes them eligible for compounding. However, the FDA does not review compounded versions of medications on the drug shortage list for safety, quality or effectiveness, the FDA warns.According to the FDA warning, the agency has received adverse event reports after patients used compounded versions of these drugs, and warns that it has also received reports that some compounding pharmacies are using a salt form of semaglutide, such as semaglutide sodium and semaglutide acetate.The salt forms of semaglutide are different active ingredients than the semaglutide used in standard Ozempic and Wegovy, the agency warns. The FDA indicates it is unaware of any means of compounding the salt forms of semaglutide which would meet the agencyโs requirements for compounding the two drugs.Find Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONFind Out If You Have a LawsuitWere you prescribed Ozempic, Wegovy or Mounjaro?Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONOn April 27, the FDA sent a letter to the National Association Boards of Pharmacy, warning them about the problem.โWe are aware that in some cases compounders may be using salt forms of semaglutide, including semaglutide sodium and semaglutide acetate,โ the agency wrote. โWe are not aware of any basis for compounding a drug using these semaglutide salts that would meet federal law requirements that limit the types of active ingredients that can be used in compounding.โFDA Recommendations for Patients and DoctorsThe agency does not say what kinds of adverse events have been reported in connection to the compounded drugs, nor does it say what types of adverse events may be linked to the use of semaglutide salts in compounded drugs.The FDA warns patients to be aware of the risk of compounding pharmacies using semaglutide salts, indicating they have not been proven to be safe or effective. Patients should only obtain the prescription-only drugs with a prescription and from a licensed health care provider. They should also only use compounding pharmacies which are state-licensed, or outsourcing facilities registered with the FDA, the agency advises.Healthcare professionals should also be aware of the problem if they are considering working with compounders to meet the needs of patients, the FDA advises.Ozempic Hair Loss ConcernsThe warning comes amid increasing reports that Ozempic side effects have been linked to hair loss when using the diabetes drug as a weight loss treatment.Some doctors have claimed hair loss after Ozempic use is a natural result of rapid weight loss. This effect is known as telogen effluvium. However, Ozempic may also cause hormonal shifts which can also trigger early onset pattern hair loss in men and women, known as androgenic alopecia, which is progressive and continues to worsen over time. This can lead to permanent hair loss, some health experts warn.Last month the founder of The American Hair Loss Association (AHLA) and The International Alliance of Hair Restoration Surgeons, warned against misuse of Ozempic for weight loss in an editorial in Dermatology Times, indicating that the hair loss experts do not recommend the off-label use of the diabetes drug. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Compounding Pharmacy, Diabetes, Diabetes Drugs, Hair Loss, Ozempic, Wegovy, Weight Loss Find Out If You Qualify for Ozempic or Wegovy CompensationMore Ozempic, Wegovy and Mounjaro Lawsuit Stories FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026 Ozempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks October 30, 2026 GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind October 13, 2026 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: today)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026) Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 3 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026) Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 4 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk November 9, 2026
Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: today)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026)
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 3 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 4 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)